Transforming growth factor β-1 (TGF-β1) is a serum biomarker of radiation induced fibrosis in patients treated with intracavitary accelerated partial breast irradiation: Preliminary results of a prospective study

International Journal of Radiation Oncology Biology Physics

Volumn 87, Issue 5, 2013, Pages 1030-1036

  Boothe, Dustin L ^a   Coplowitz, Shana ^a   Greenwood, Eleni ^a   Barney, Christian L ^b   Christos, Paul J ^a   Parashar, Bhupesh ^a   Nori, Dattatreyudu ^a   Chao, K S Clifford ^a   Wernicke, A Gabriella ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCELERATED PARTIAL BREAST IRRADIATION; AMERICAN JOINT COMMITTEE ON CANCERS; AREA UNDER THE CURVES; ENZYME-LINKED IMMUNOASSAYS; METHODS AND MATERIALS; RECEIVER OPERATING CHARACTERISTIC CURVES; SENSITIVITY AND SPECIFICITY; TRANSFORMING GROWTH FACTORS;

BODY FLUIDS; DERMATITIS; IRRADIATION; PATIENT MONITORING; SURGERY;

RADIOTHERAPY;

BIOLOGICAL MARKER; TRANSFORMING GROWTH FACTOR BETA1;

ACCELERATED PARTIAL BREAST IRRADIATION VIA INTRACAVITARY BRACHYTHERAPY; ADULT; AGED; ANALYTICAL EQUIPMENT; ARTICLE; BALLOON; BLOOD SAMPLING; BRACHYTHERAPY; BRACHYTHERAPY DEVICE; BREAST; BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; DOSIMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IRRADIATION; PARTIAL MASTECTOMY; PATIENT MONITORING; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EQUIPMENT; RADIATION INDUCED FIBROSIS; RADIATION INJURY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SKIN; TREATMENT OUTCOME; TREATMENT PLANNING; BLOOD; BREAST NEOPLASMS; CASE CONTROL STUDY; FIBROSIS; FOLLOW UP; MIDDLE AGED; PATHOLOGY; POSTMENOPAUSE; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; RADIATION PNEUMONIA; RADIATION RESPONSE; REFERENCE VALUE; TIME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRACHYTHERAPY; BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PREOPERATIVE PERIOD; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIATION PNEUMONITIS; REFERENCE VALUES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SKIN; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84888307922     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.08.045     Document Type: Article

References (36)

1. D.W. Arthur, and F.A. Vicini Accelerated partial breast irradiation as a part of breast conservation therapy J Clin Oncol 23 2005 1726 1735
2. F.A. Vicini, L. Kestin, and P. Chen Limited-field radiation therapy in the management of early-stage breast cancer J Natl Cancer Inst 95 2003 1205 1210
3. J.B. Strauss, and A. Dickler Accelerated partial breast irradiation utilizing balloon brachytherapy techniques Radiother Oncol 91 2009 157 165
4. P.R. Benitez, M.E. Keisch, and F. Vicini Five-year results: The initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer Am J Surg 194 2007 456 462
5. S. Brown, M. McLaughlin, and K. Pope Initial radiation experience evaluating early tolerance and toxicities in patients undergoing accelerated partial breast irradiation using the Contura multi-lumen balloon breast brachytherapy catheter Brachytherapy 8 2009 227 233
6. K.K. Chao, F.A. Vicini, and M. Wallace Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: The William Beaumont Hospital experience Int J Radiat Oncol Biol Phys 69 2007 32 40
7. M. Wallace, A. Martinez, and C. Mitchell Phase I/II study evaluating early tolerance in breast cancer patients undergoing accelerated partial breast irradiation treated with the MammoSite balloon breast brachytherapy catheter using a 2-day dose schedule Int J Radiat Oncol Biol Phys 77 2010 531 536
8. K. Fleckenstein, B. Gauter-Fleckenstein, and I.L. Jackson Using biological markers to predict risk of radiation injury Semin Radiat Oncol 7 2007 89 98
9. A.G. Wernicke, E.A. Greenwood, and S. Coplowitz Tissue compliance meter is a more reproducible method of measuring radiation-induced fibrosis than late effects of normal tissue-subjective objective management analytical in patients treated with intracavitary brachytherapy accelerated partial breast irradiation: results of a prospective trial Breast J 19 2013 250 258
10. M.S. Anscher Targeting the TGF-beta1 pathway to prevent normal tissue injury after cancer therapy Oncologist 15 2010 350 359
11. S.M. Bentzen Preventing or reducing late side effects of radiation therapy: Radiobiology meets molecular pathology Nat Rev Cancer 6 2006 702 713
12. M. Martin, J. Lefaix, and S. Delanian TGF-beta1 and radiation fibrosis: A master switch and a specific therapeutic target? Int J Radiat Oncol Biol Phys 47 2000 277 290
13. H. Landmark-Høyvik, V. Dumeaux, and K.V. Reinertsen Blood gene expression profiling of breast cancer survivors experiencing fibrosis Int J Radiat Oncol Biol Phys 79 2011 875 883
14. I. Turesson, J. Nyman, and E. Holmberg Prognostic factors for acute and late skin reactions in radiotherapy patients Int J Radiat Oncol Biol Phys 36 1996 1065 1075
15. J. Alsner, C.N. Andreassen, and J. Overgaard Genetic markers for prediction of normal tissue toxicity after radiotherapy Semin Radiat Oncol 18 2008 126 135
16. S. Quarmby, H. Fakhoury, and E. Levine Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients Int J Radiat Biol 79 2003 137 143
17. M.H. Barcellos-Hoff How do tissues respond to damage at the cellular level? The role of cytokines in irradiated tissues Radiat Res 150 5 Suppl 1998 S109 S120
18. F. Boyd, and J. Massagué Transforming growth factor inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor J Biol Chem 264 1989 2272 2278
19. S.M. Bentzen, M. Parliament, and J.O. Deasy Biomarkers and surrogate endpoints for normal-tissue effects of radiation therapy: The importance of dose-volume effects Int J Radiat Oncol Biol Phys 76 3 Suppl 2010 S145 S150
20. M.S. Anscher, F.M. Kong, and K. Andrews Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis Int J Radiat Oncol Biol Phys 41 1998 1029 1035
21. G.C. Barnett, R.M. Elliott, and J. Alsner Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity Radiother Oncol 105 2012 289 295
22. C. Li, P.B. Wilson, and E. Levine TGF-beta1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis Int J Cancer 84 1999 155 159
23. S.M. Bentzen, W. Dorr, and M.S. Anscher Normal tissue effects: Reporting and analysis Semin Radiat Oncol 13 2003 189 202
24. Keish M, Arthur D, Patel R, et al. American Brachytherapy Society Breast Brachytherapy Task Group. American Brachytherapy Society 2007. Available from: http://www.americanbrachytherapy.org/resources/abs-breast-brachytherapy- taskgroup.pdf. Accessed February 18, 2013.
25. D.S. Benjamin, W.A. Douglas, and A.B. Thomas Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO) Int J Radiat Oncol Biol Phys 74 2009 787 1001
26. A.G. Wernicke, B. Parashar, and F. Kulidzhanov Prospective study validating inter- and intraobserver variability of tissue compliance meter in breast tissue of healthy volunteers: Potential implications for patients with radiation-induced fibrosis of the breast Int J Radiat Oncol Biol Phys 80 2011 39 46
27. S.M. Bentzen, and M. Overgaard Early and late normal tissue injury after postmastectomy radiotherapy Recent Results Cancer Rec 130 1993 59 78
28. M.T. Milano, L.S. Constine, and P. Okunieff Normal tissue tolerance dose metrics for radiation therapy of major organs Semin Radiat Oncol 17 2007 131 140
29. F.M. Kong, C. Pan, and A. Eisbruch Physical models and simpler dosimetric descriptors of radiation late toxicity Semin Radiat Oncol 17 2007 108 120
30. B.S. Rosenstein, S.C. Lymberis, and S.C. Formenti Biologic comparison of partial breast irradiation protocols Int J Radiat Oncol Biol Phys 60 2004 1393 1404
31. F. Vicini, P.D. Beitsch, and C.A. Quiet Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI) Cancer 112 2008 758 766
32. M.S. Anscher, L.B. Marks, and T.D. Shafman Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation J Clin Oncol 17 2001 3758 3765
33. F.M. Kong, X. Ao, and L. Wang The use of blood biomarkers to predict radiation lung toxicity: A potential strategy to individualize thoracic radiation therapy Cancer Control 15 2008 140 150
34. C.N. Andreassen, J. Alsner, and M. Overgaard Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes Radiother Oncol 69 2003 127 135
35. S. Reuther, E. Metzke, and M. Bonin No effect of the transforming growth factor β1 promoter polymorphism C-509T on TGFB1 gene expression, protein secretion, or cellular radiosensitivity Int J Radiat Oncol Biol Phys 85 2013 460 465
36. F.M. Kong, M.S. Anscher, and T. Murase Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor Ann Surg 222 1995 155 162